Inventor · disambiguated record
Chengzu Long
Also filed as: LONG CHENGZU
0 granted patents·8 pending applications·0 citations·filing 2015–2023
Top patents by PatentIndex Score
8 records- 0163US2023069642A1Precise template-free correction of brca1 mutation in human cells via genome editingUNIV NEW YORK·Filed 2022·Application pending·0 cites
- 0263US2022072156A1Prevention of muscular dystrophy by crispr/cas9-mediated gene editingUNIV TEXAS·Filed 2021·Application pending·0 cites
- 0352US2020370042A1Compositions and methods for correcting dystrophin mutations in human cardiomyocytesUNIV TEXAS·Filed 2019·Application pending·0 cites
- 0450US2016058889A1Prevention of muscular dystrophy by crispr/cas9-mediated gene editingUNIV TEXAS·Filed 2015·Application pending·0 cites
- 0547US2023348878A1ENHANCEMENT OF SAFETY AND PRECISION FOR CRISPR-Cas INDUCED GENE EDITING BY VARIANTS OF DNA POLYMERASE USING CAS-PLUS VARIANTSUNIV NEW YORK·Filed 2023·Application pending·0 cites
- 0642US2019364862A1Dmd reporter models containing humanized duchenne muscular dystrophy mutationsUNIV TEXAS·Filed 2017·Application pending·0 cites
- 0740US2023407275A1Enhancement of predictable and template-free gene editing by the association of cas with dna polymeraseUNIV NEW YORK·Filed 2021·Application pending·0 cites
- 0839US2020046854A1Prevention of muscular dystrophy by crispr/cpf1-mediated gene editingUNIV TEXAS·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chengzu Long files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →